First Time Loading...

Uniqure NV
NASDAQ:QURE

Watchlist Manager
Uniqure NV Logo
Uniqure NV
NASDAQ:QURE
Watchlist
Price: 4.69 USD 0.21% Market Closed
Updated: May 5, 2024

Uniqure NV
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Uniqure NV
Revenue Peer Comparison

Comparables:
PHARM
PRQR
ARGX
MRUS
N
NAMS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Uniqure NV
NASDAQ:QURE
Revenue
$15.8m
CAGR 3-Years
-25%
CAGR 5-Years
7%
CAGR 10-Years
14%
Pharming Group NV
AEX:PHARM
Revenue
$245.3m
CAGR 3-Years
5%
CAGR 5-Years
11%
CAGR 10-Years
43%
ProQR Therapeutics NV
NASDAQ:PRQR
Revenue
€9.5m
CAGR 3-Years
0%
CAGR 5-Years
11%
CAGR 10-Years
N/A
argenx SE
XBRU:ARGX
Revenue
$1.2B
CAGR 3-Years
210%
CAGR 5-Years
121%
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Revenue
$43.9m
CAGR 3-Years
14%
CAGR 5-Years
3%
CAGR 10-Years
N/A
N
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
Revenue
€97.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Uniqure NV's Revenue?
Revenue
15.8m USD

Based on the financial report for Dec 31, 2023, Uniqure NV's Revenue amounts to 15.8m USD.

What is Uniqure NV's Revenue growth rate?
Revenue CAGR 10Y
14%

Over the last year, the Revenue growth was -85%. The average annual Revenue growth rates for Uniqure NV have been -25% over the past three years , 7% over the past five years , and 14% over the past ten years .